Work

Supplemental Figure 3 from BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer

Year: 2023

Type: supplementary-materials

Abstract: De-recruitment of BRD2/3/4 from the SRSF1 and U2AF1 promoter by JQ1.

DOI: 10.1158/1541-7786.22514314.v1

Authors: Irfan A. Asangani, Kari Wilder-Romans, Vijaya L. Dommeti, Pranathi M. Krishnamurthy, Ingrid J. Apel, June Escara-Wilke, Stephen R. Plymate, Nora M. Navone, Shaomeng Wang, Felix Y. Feng, Arul M. Chinnaiyan

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362536893

Cites:

Cited by:

Related to: 10